Cytegen
Wauwatosa, US · Founded 2014 · Delaware corporation
Founders & leadership
MH
MICHAEL HARTENamed on SEC filing
NG
NURAY GEORGE UGRASNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.1M disclosed across 2 rounds · 2018–2021
▶$1.1MraisedJan 2022 · 3 investors · Other
▶$1.1MraisedJan 2022 · 3 investors · Other
Officers, directors & promoters on the filing
- GEORGE UGRAS NURAYExecutive Officer, Director
- Amount sold
- $1.1M
- Minimum investment
- $100K
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 04
▶$1MraisedApr 2018 · 4 investors · BiotechnologyRule 506(b)
▶$1MraisedApr 2018 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- MICHAEL HARTEDirector
- NURAY GEORGE UGRASExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $1M
- Minimum investment
- $50K
- Proceeds to insiders
- $75K
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Cytegen raised?
- Cytegen has disclosed $2.1M raised across 2 rounds.
- Where is Cytegen headquartered?
- Cytegen is headquartered in Wauwatosa, US.